Drug Type Small molecule drug |
Synonyms CBM, Athyromazole, Carbethoxymethimazole + [7] |
Target |
Action inhibitors |
Mechanism TPO inhibitors(Thyroid peroxidase inhibitors) |
Active Indication |
Inactive Indication- |
Originator Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhaseApproved |
First Approval Date Australia (23 May 2012), |
Regulation- |
Molecular FormulaC7H10N2O2S |
InChIKeyCFOYWRHIYXMDOT-UHFFFAOYSA-N |
CAS Registry22232-54-8 |
| KEGG | Wiki | ATC | Drug Bank |
|---|---|---|---|
| D07616 | Carbimazole |
| Indication | Country/Location | Organization | Date |
|---|---|---|---|
| Thyrotoxicosis | Australia | 23 May 2012 | |
| Hyperthyroidism | Australia | 23 May 2012 |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Graves Disease | Clinical | Saudi Arabia | 22 May 2024 |





